KPT.TO Quote, Financials, Valuation and Earnings

CENTR Brands Corp. has a net margin of -- compared to KP Tissue, Inc.'s net margin of -1601.07%. KP Tissue, Inc.'s return on equity of 5.6% beat CENTR Brands Corp.'s return on equity of -674.23%.

KP Tissue, Inc. has a consensus price target of $10.50, signalling upside risk potential of 0.48%. On the other hand CENTR Brands Corp. has an analysts' consensus of -- which suggests that it could fall by --. Given that KP Tissue, Inc. has higher upside potential than CENTR Brands Corp., analysts believe KP Tissue, Inc. is more attractive than CENTR Brands Corp..

KP Tissue, Inc. has a beta of 0.258, which suggesting that the stock is 74.168% less volatile than S&P 500. In comparison CENTR Brands Corp. has a beta of -3.753, suggesting its less volatile than the S&P 500 by 475.287%.

KP Tissue, Inc. has a quarterly dividend of $0.18 per share corresponding to a yield of 6.89%. CENTR Brands Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. KP Tissue, Inc. pays 295.2% of its earnings as a dividend. CENTR Brands Corp. pays out -- of its earnings as a dividend.

KP Tissue, Inc. quarterly revenues are --, which are smaller than CENTR Brands Corp. quarterly revenues of --. KP Tissue, Inc.'s net income of $1.6M is higher than CENTR Brands Corp.'s net income of -$37.9K. Notably, KP Tissue, Inc.'s price-to-earnings ratio is 26.88x while CENTR Brands Corp.'s PE ratio is 2.13x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for KP Tissue, Inc. is 1,406.61x versus -- for CENTR Brands Corp.. Usually stocks with elevated PS ratios are considered overvalued.

Forte Group Holdings, Inc. has a net margin of -- compared to KP Tissue, Inc.'s net margin of -8012.46%. KP Tissue, Inc.'s return on equity of 5.6% beat Forte Group Holdings, Inc.'s return on equity of -913.37%.

KP Tissue, Inc. has a consensus price target of $10.50, signalling upside risk potential of 0.48%. On the other hand Forte Group Holdings, Inc. has an analysts' consensus of -- which suggests that it could fall by --. Given that KP Tissue, Inc. has higher upside potential than Forte Group Holdings, Inc., analysts believe KP Tissue, Inc. is more attractive than Forte Group Holdings, Inc..

KP Tissue, Inc. has a beta of 0.258, which suggesting that the stock is 74.168% less volatile than S&P 500. In comparison Forte Group Holdings, Inc. has a beta of -0.311, suggesting its less volatile than the S&P 500 by 131.053%.

KP Tissue, Inc. has a quarterly dividend of $0.18 per share corresponding to a yield of 6.89%. Forte Group Holdings, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. KP Tissue, Inc. pays 295.2% of its earnings as a dividend. Forte Group Holdings, Inc. pays out -- of its earnings as a dividend.

KP Tissue, Inc. quarterly revenues are --, which are smaller than Forte Group Holdings, Inc. quarterly revenues of $30.5K. KP Tissue, Inc.'s net income of $1.6M is higher than Forte Group Holdings, Inc.'s net income of -$2.4M. Notably, KP Tissue, Inc.'s price-to-earnings ratio is 26.88x while Forte Group Holdings, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for KP Tissue, Inc. is 1,406.61x versus 37.61x for Forte Group Holdings, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

SBD Capital Corp. has a net margin of -- compared to KP Tissue, Inc.'s net margin of -2561.54%. KP Tissue, Inc.'s return on equity of 5.6% beat SBD Capital Corp.'s return on equity of --.

KP Tissue, Inc. has a consensus price target of $10.50, signalling upside risk potential of 0.48%. On the other hand SBD Capital Corp. has an analysts' consensus of -- which suggests that it could fall by --. Given that KP Tissue, Inc. has higher upside potential than SBD Capital Corp., analysts believe KP Tissue, Inc. is more attractive than SBD Capital Corp..

KP Tissue, Inc. has a beta of 0.258, which suggesting that the stock is 74.168% less volatile than S&P 500. In comparison SBD Capital Corp. has a beta of -0.674, suggesting its less volatile than the S&P 500 by 167.427%.

KP Tissue, Inc. has a quarterly dividend of $0.18 per share corresponding to a yield of 6.89%. SBD Capital Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. KP Tissue, Inc. pays 295.2% of its earnings as a dividend. SBD Capital Corp. pays out -- of its earnings as a dividend.

KP Tissue, Inc. quarterly revenues are --, which are smaller than SBD Capital Corp. quarterly revenues of $1.3K. KP Tissue, Inc.'s net income of $1.6M is higher than SBD Capital Corp.'s net income of -$33.3K. Notably, KP Tissue, Inc.'s price-to-earnings ratio is 26.88x while SBD Capital Corp.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for KP Tissue, Inc. is 1,406.61x versus 42.50x for SBD Capital Corp.. Usually stocks with elevated PS ratios are considered overvalued.